News Focus
News Focus
icon url

jbog

02/13/17 9:16 AM

#209035 RE: WorstLuck #209027

I've always held Allergan in high regard. On the other hand I'd chuckle whenever I saw CoolSculpting adds.

Is this real or is this just like those Tummy Shakers that my mom used 50 years ago.
icon url

haysaw

02/13/17 9:16 AM

#209036 RE: WorstLuck #209027

Interestingly, another medical aesthetics company based in Israel (ELOS) is also getting buyout interest:

Apax Partners in talks to buy Israel's Syneron Medical -report

Reuters February 13, 2017

JERUSALEM, Feb 13 (Reuters) - British private equity fund Apax Partners is in talks to buy Israel-based Syneron Medical , an aesthetic device company, for $350-$400 million, Israeli financial daily Calcalist reported on Monday.

Representatives from Apax met Syneron executives in Israel last week and the talks are being managed by Barclays, according to Calcalist, a leading Israeli publication, which did not name its sources.

Spokespeople in Israel for Apax and Barclays would not comment on the report. Officials at Syneron were not reachable for immediate comment.

Syneron says its products have a range of applications, like body contouring, hair removal and wrinkle reduction. The products are sold under two brands, Syneron and Candela.
icon url

DewDiligence

02/14/17 12:55 PM

#209073 RE: WorstLuck #209027

HOLX acquires CYNO for $66/sh in cash—a 28% premium to yesterday’s close:

http://finance.yahoo.com/news/hologic-acquire-cynosure-leader-medical-130000368.html

The nominal EV for the transaction is $1.44B.

CYNO makes lasers and radio-frequency devices for cosmetic procedures. It’s curious that deals to acquire ZLTQ (#msg-128649430) and CYNO were announced on successive days.